Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01047514 · ClinicalTrials.gov registry record · Phase 2
Healthier Living Canada
A Phase 2 study of Asthma and Chronic Disease, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 297
- Enrollment target
- 1
- Study location
NCT01047514: Completed Phase 2 study of Asthma and Chronic Disease, sponsored by Stanford University.
NCT01047514 is a Phase 2 study of Asthma and Chronic Disease that has completed, run by Stanford University. The registered enrollment target is 297 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01047514, a Phase 2 study of Asthma and Chronic Disease, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 297 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of an online Chronic Disease Self-Management Program for participants in Canada living with chronic health conditions. This pilot will look for improvements in health status, health behaviors and health care utilization.
Conditions Studied
Interventions
- BEHAVIORAL Chronic Disease Self-Management Online Workshop
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 297 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-08 |
| Phase | Phase 2 |
What the finished NCT01047514 record still lists
NCT01047514 is an interventional study that assigns participants to a tested intervention. The registered 297 participants enrollment target is mid-sized for trials with a published cap, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Chronic Disease Self-Management Online Workshop is the first listed.
NCT01047514 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01047514 about?
NCT01047514 is a clinical study titled "Healthier Living Canada". This study will evaluate the effectiveness of an online Chronic Disease Self-Management Program for participants in Canada living with chronic health conditions. This pilot will look for improvements in health status, health behaviors and health care utilization.
What is the current status of trial NCT01047514?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 297 participants. The study started on 2010-01. Estimated completion is 2012-08.
What conditions does trial NCT01047514 study?
This clinical trial studies the following conditions: Asthma, Chronic Disease.
What interventions are being tested in trial NCT01047514?
The interventions under investigation include: Chronic Disease Self-Management Online Workshop (BEHAVIORAL).
Who is sponsoring clinical trial NCT01047514?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01047514 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01047514's enrollment target sits among peer trials
297 130th of 374 higher than 245 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06309160 · 297 participants · NA
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
- NCT06375811 · 297 participants · Phase 3
Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp
- NCT07222215 · 297 participants · Phase 2
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
- NCT06305624 · 298 participants · NA
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia